This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Sloan-Kettering Institute for Cancer Research, Invitrogen Corporation. Active years: 2010-2012.
Company Filing History:
2 out of 517 
1 out of 143 
Years Active: 2010-2012
Title: Robert Marcil: Innovator in DNA and RNA Research
Introduction
Robert Marcil is a notable inventor based in Carlsbad, California. He has made significant contributions to the field of molecular biology, particularly in the area of DNA and RNA interactions. With a total of 2 patents, his work has advanced our understanding of genetic material manipulation.
Latest Patents
Marcil's latest patents include innovative methods for covalently joining DNA strands to RNA strands using vaccinia topoisomerase. The first patent outlines a method for tagging the 5' end of an RNA molecule and provides a DNA-RNA molecule that has been joined in vitro. The second patent details a process for forming a topoisomerase-DNA intermediate and subsequently covalently joining the DNA strand to the RNA strand. These inventions also include methods for isolating and cloning full-length gene sequences using capped mRNA.
Career Highlights
Throughout his career, Robert Marcil has worked with prestigious organizations such as the Sloan-Kettering Institute for Cancer Research and Invitrogen Corporation. His experience in these institutions has allowed him to develop and refine his innovative techniques in genetic research.
Collaborations
Marcil has collaborated with esteemed colleagues, including Stewart Shuman and JoAnn Sekiguchi. Their combined expertise has contributed to the advancement of research in molecular biology.
Conclusion
Robert Marcil's contributions to the field of DNA and RNA research are significant and impactful. His innovative patents and collaborations highlight his dedication to advancing scientific knowledge.